Home Markets Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210

You May Also Like

Vitol CEO sees slight drop in US oil output this year due to lower prices

Nvidia to attend China supply-chain expo in July for first time, CCTV reports

Chinese automakers build significant leads in zero-emission vehicle market, research finds

Eli Lilly close to buying gene editing firm Verve for $1.3 bln- FT

US and UK announce a trade deal, but steel imports unresolved

TSX ended higher amid G7 summit, Israel-Iran tensions